![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Siegfried Ltd. Zofingen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Nifedipine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R2-CEP 1995-005 - Rev 02
This Chemical Type CEP, issued on July 30, 2012, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 627 associated with this CEP further emphasizes